Lupin Limited has informed the Exchange regarding a press release dated March 23, 2023, titled “Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets.”…….
Subscribe To Our Free Newsletter |
Lupin Limited has informed the Exchange regarding a press release dated March 23, 2023, titled “Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets.”…….
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!